Prostatis Group’s Bank of America BAC Stock Holding History

Prostatis Group’s Portfolio BAC Stock Details BAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,335	Closed	-$406K	–	191
2026 Q1	$406K	Buy	8,335 +700	+9%	+$36.1K	0.1%	114
2025 Q4	$420K	Buy	+7,635	New	+$404K	0.1%	112

Other funds holding BAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prostatis Group's BAC Position: Q2 2026 in Review

Prostatis Group sold out of Bank of America (BAC) in Q2 2026, closing a stake of 8,335 shares — an estimated $406K sold.

Prostatis Group first reported a position in BAC in Q4 2025 and held it in 2 quarters. The position peaked at $420K in Q4 2025. 3,597 funds tracked by Wall St. Rank hold BAC as of Q2 2026.

Prostatis Group reported no remaining Bank of America position as of Q2 2026 after selling out during the quarter.
Prostatis Group sold 8,335 Bank of America shares in Q2 2026, an estimated $406K.
Prostatis Group first reported a position in Bank of America in Q4 2025 and held it in 2 quarters.
Prostatis Group's Bank of America position peaked at $420K in Q4 2025.
3,597 funds tracked by Wall St. Rank held Bank of America as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.